142 related articles for article (PubMed ID: 22436517)
1. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
[TBL] [Abstract][Full Text] [Related]
2. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
Lommatzsch PK; Werschnik C; Schuster E
Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
[TBL] [Abstract][Full Text] [Related]
4. [Iodine-125-brachytherapy of malignant choroid melanoma. II: Long-term functional outcome].
Kreissig I; Rose D; Simader E
Klin Monbl Augenheilkd; 1996 Jul; 209(1):7-12. PubMed ID: 8965481
[TBL] [Abstract][Full Text] [Related]
5. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
6. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma.
Wilson MW; Hungerford JL
Ophthalmology; 1999 Aug; 106(8):1579-87. PubMed ID: 10442907
[TBL] [Abstract][Full Text] [Related]
7. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation].
Guthoff R; Frischmuth J; Jensen OA; Bjerrum K; Prause JU
Klin Monbl Augenheilkd; 1992 Apr; 200(4):257-61. PubMed ID: 1614086
[TBL] [Abstract][Full Text] [Related]
8. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects.
Jones R; Gore E; Mieler W; Murray K; Gillin M; Albano K; Erickson B
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):989-95. PubMed ID: 11958893
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
[TBL] [Abstract][Full Text] [Related]
10. [Curietherapy using a ruthenium and iridium disk in the treatment of choroid melanoma].
Gérard JP; Grange JD; Romestaing P; Sentenac I; De Laroche G; Montbarbon X; Mahe M; Salerno N; Baude JP; Bonnet M
Ann Radiol (Paris); 1989; 32(2):107-11. PubMed ID: 2757334
[TBL] [Abstract][Full Text] [Related]
11. [Transpupillary thermotherapy of choroidal melanoma].
Schneider H; Fischer K; Fietkau R; Guthoff RF
Klin Monbl Augenheilkd; 1999 Feb; 214(2):90-5. PubMed ID: 10218201
[TBL] [Abstract][Full Text] [Related]
12. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16.
Melia BM; Abramson DH; Albert DM; Boldt HC; Earle JD; Hanson WF; Montague P; Moy CS; Schachat AP; Simpson ER; Straatsma BR; Vine AK; Weingeist TA;
Ophthalmology; 2001 Feb; 108(2):348-66. PubMed ID: 11158813
[TBL] [Abstract][Full Text] [Related]
13. Palladium-103 plaque radiotherapy for choroidal melanoma: results of a 7-year study.
Finger PT; Berson A; Szechter A
Ophthalmology; 1999 Mar; 106(3):606-13. PubMed ID: 10080222
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106.
Sallet G; Amoaku WM; Lafaut BA; Van Liefferinge B; De Laey JJ
Bull Soc Belge Ophtalmol; 1996; 263():27-37. PubMed ID: 9396191
[TBL] [Abstract][Full Text] [Related]
15. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].
Brovkina AF; Zarubeí GD; Val'skií VV
Vestn Oftalmol; 1997; 113(3):14-6. PubMed ID: 9265351
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients].
Schmidt JC; Brieden-Azvedo S; Nietgen GW
Klin Monbl Augenheilkd; 2001 Dec; 218(12):800-4. PubMed ID: 11805872
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
18. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
19. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
20. Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma.
O'Day RFJ; Roelofs KA; Negretti GS; Hay G; Arora AK; Stoker I; Damato BE; Sagoo MS; Cohen VML
Eye (Lond); 2023 Apr; 37(5):959-965. PubMed ID: 35140328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
